Virtual Reality Versus Mental Practice On Balance And Gait In Patients With Multiple Sclerosis
This study is conducted to:
- Investigate the effect of virtual reality based training on balance and risk of falling.
- Investigate the effect of virtual reality based training on gait.
- Investigate the effect of mental practice on balance and risk of falling.
- Investigate the effect of mental practice on gait.
- Compare between the effect of virtual reality based training and mental practice on balance and gait
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Background: Multiple sclerosis affects the central integration of sensory afferents that causes disturbance of balance, postural control and gait. Exercise interventions performed through VR applications encourage participants to engage in challenging tasks that integrate motor and cognitive demands, enhance patients' sensory processing and integration systems and allows them to receive information feedback and improve the motivation of training. Mental Practice is a complex cognitive operation that is possible thanks to the use of sensory and perceptive processes that allow an individual to reactivate specific motor actions in the working memory.
Purpose: This study is conducted to Investigate the effect of virtual reality based training on balance and risk of falling, Investigate the effect of virtual reality based training on gait, Investigate the effect of mental practice on balance and risk of falling, Investigate the effect of mental practice on gait and to compare between the effect of virtual reality based training and mental practice on balance and gait.
Methods: Fifty four patients of both sexes with relapsing remitting MS (RRMS). The patients will be diagnosed as having RRMS based on careful clinical examination by neurologist and diagnosis will be confirmed by radiological investigations as magnetic resonance imaging (MRI). Patients will be recruited from the outpatient clinic of Faculty of Physical Therapy, Pharos University in Alexandria and private clinics. Patients in this study will be randomly divided into three groups.
- Group (I) which will include 18 patients who will receive mental practice in addition to selected physical therapy .
- Group (II) which will include 18 patients who will receive virtual reality based training in addition to selected physical therapy.
- Group (III) which will include 18 patients who will receive selected physical therapy.
The treatment will be conducted 3 sessions per week for 6 weeks for 45 minutes.
Results: Data analysis with 2-way mixed Design MANOVA will be used to compare the groups for normally distributed data and Kruskal Wallis and Mann-Whitney tests will be used to compare the groups for non-parametric and not normally distributed data.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Ola Z Asal, BSc
- Numéro de téléphone: 00201023830508
- E-mail: ola25jan@gmail.com
Sauvegarde des contacts de l'étude
- Nom: Nagwa I Rehab, PhD
- Numéro de téléphone: 00201008124920
- E-mail: Nagwa1102010@yahoo.com
Lieux d'étude
-
-
Giza Governorate
-
Giza, Giza Governorate, Egypte
- Recrutement
- Faculty of Physical Therapy, Cairo University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Patients with RRMS.
- Patient's age will be range from 20 - 35 years..
- Patients are able to walk 10 meter with or without assistance.
- Patients with ≤ 6 according to an Expanded Disability Status Scale (EDSS).
- Patients are cognitively able to follow instructions.
- Patient's body mass index (BMI) will be ranged from 18.5 to 29.99 Kg/m2.
Exclusion Criteria:
- Patients with MS relapse in the last 30 days.
- Visual impairments interfering with VR.
- Severe spasticity or orthopaedic deformity.
- Recent musculoskeletal injury.
- History of epilepsy or motion sickness with VR.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Réalité virtuelle
|
The virtual environment presented via Head Mounted Display (HMD) has three-dimensional presentation and the panoramic view that covers the users' field of view, it facilitates immersion in the virtual and distraction from the real world |
|
Expérimental: Mental Practice
|
Mental Practice is among the recommended strategies to enhance performance. MP is a symbolic exercise, involving repeated mental imagery in the absence of any visible muscle contraction. |
|
Expérimental: Selected Physical Therapy Program
|
Dual tasking and Task oriented training in static and dynamic forms |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Gait
Délai: 6 weeks
|
spatial, temporal and angular parameters as cadence, step length and range of motion of hip, knee and ankle will be measured using software analysis "Kinovea" Kinovea is a free, open-source 2D video analysis software. It does not generate a single composite "score". Instead, it measures quantitative biomechanical and kinematic metrics from recorded video. |
6 weeks
|
|
Gait
Délai: 6 weeks
|
"10 minutes walk test" will be performed pre and post treatment by asking the patient to walk through a 12 meter walkway and calculate the time for 10 meters in tha walkway in two walking speeds( normal - fast) for 2 or 3 trials of each speed Speed > 1.2 m/s: Normal / Community AmbulatorAble to safely cross street intersections and navigate crowded environments. 0.8 - 1.2 m/s: Limited Community Ambulator/ Able to walk outdoors independently 0.4 - 0.8 m/s: Household Ambulator/ Mostly restricted to indoor walking; requires assistance or equipment outdoors. < 0.4 m/s: Severe Functional Limitation |
6 weeks
|
|
Balance
Délai: 6 weeks
|
static and dynamic balance will be assessed using "Berg Balance Scale" The Berg Balance Scale (BBS) is a 14-item clinical assessment scale designed to measure static balance and dynamic functional mobility, Point Scale: Each of the 14 tasks is rated on a 0 to 4 ordinal scale based on safety, independence, time held, or distance reached, Scores are summed across all items for a overall score ranging from 0 to 56 points (higher scores reflect better balance and mobility). |
6 weeks
|
|
Balance
Délai: 6 weeks
|
"Timed Up and Go" test giving numerical data pre and post treatment about balance and risk of falling Test is scored entirely by time (in seconds): Time < 10 seconds: Normal / Completely IndependentFreely mobile; minimal to no fall risk 10 - 19 seconds: Mostly Independent, Reasonable balance and gait speed, generally low fall risk 20 - 29 seconds: Variable MobilityImpaired mobility, slower gait speed > 30 seconds: Severely Impaired, high fall risk |
6 weeks
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Directeur d'études: Nagwa I Rehab, PhD, Cairo University
- Directeur d'études: Rania M Tawfik, PhD, Cairo University
- Directeur d'études: Ebtesam M Fahmy, PhD, Cairo University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- P.T.REC/012/006172
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .